Mirna-mediated GALNT modulation of invasion and immune suppression: A sweet deal for metastatic cells

OncoImmunology

Volumn 1, Issue 5, 2012, Pages 746-748

  Gaziel Sovran, Avital ^a   Hernando, Eva ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GalNAc Ts; GALNT; Glycosylation; Immunosuppression; Melanoma; Metastasis; Mir 30d; Mirna

Indexed keywords

INTERLEUKIN 10; MICRORNA; MICRORNA 30B; MICRORNA 30D; N ACETYLGALACTOSAMINE TRANSFERASE; TRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER INVASION; CELL INTERACTION; GLYCOSYLATION; HUMAN; IMMUNE DEFICIENCY; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 84886944108     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.19535     Document Type: Article

References (10)

1. Gaziel-Sovran A, Segura MF, Di Micco R, Collins MK, Hanniford D, Vega-Saenz de Miera E, et al. miR-30b/ 30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell 2011; 20:104-18; PMID:21741600; http://dx.doi.org/10.1016/j.ccr.2011.05.027
2. Hart GW, Copeland RJ. Glycomics hits the big time. Cell 2010; 143:672-6; PMID:21111227; http://dx.doi.org/10.1016/j.cell.2010.11.008
3. Rambaruth ND, Dwek MV. Cell surface glycan-lectin interactions in tumor metastasis. Acta Histochem 2011; 113:591-600; PMID:21501858; http://dx.doi.org/10.1016/j.acthis.2011.03.001
4. Ciborowski P, Finn OJ. Non-glycosylated tandem repeats of MUC1 facilitate attachment of breast tumor cells to normal human lung tissue and immobilized extracellular matrix proteins (ECM) in vitro: potential role in metastasis. Clin Exp Metastasis 2002; 19:339-45; PMID:12090474; http://dx.doi.org/10.1023/A:1015590515957
5. Garcia-Lora A, Algarra I, Garrido F. MHC class I antigens, immune surveillance, and tumor immune escape. J Cell Physiol 2003; 195:346-55; PMID: 12704644; http://dx.doi.org/10.1002/jcp.10290
6. Guda K, Moinova H, He J, Jamison O, Ravi L, Natale L, et al. Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers. Proc Natl Acad Sci U S A 2009; 106:12921-5; PMID:19617566; http://dx.doi.org/10.1073/pnas.0901454106
7. Tenno M, Ohtsubo K, Hagen FK, Ditto D, Zarbock A, Schaerli P, et al. Initiation of protein O glycosylation by the polypeptide GalNAcT-1 in vascular biology and humoral immunity. Mol Cell Biol 2007; 27:8783-96; PMID:17923703; http://dx.doi.org/10.1128/MCB.01204-07
8. Taniguchi N. Toward cancer biomarker discovery using the glycomics approach. Proteomics 2008; 8: 3205-8; PMID:18690642; http://dx.doi.org/10.1002/pmic.200890056
9. Oka H, Saito A, Ito K, Kumada T, Satomura S, Kasugai H, et al. Collaborative Hepato-Oncology Study Group of Japan. Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein. J Gastroenterol Hepatol 2001; 16:1378-83; PMID:11851836; http://dx.doi.org/10.1046/j.1440-1746.2001.02643.x
10. Miyoshi E, Nakano M. Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures. Proteomics 2008; 8:3257-62; PMID:18646007; http://dx.doi.org/10.1002/pmic.200800046